Blood tests and a new score may forecast brain bleed recovery

NCT ID NCT07728734

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Germans Trias i Pujol Hospital Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study tests whether a new scoring system, called PRO-ICH, can accurately predict how well people will recover after a spontaneous brain hemorrhage. Researchers will also check if adding certain blood markers improves the score's accuracy. The goal is to give doctors a reliable way to estimate a patient's long-term functional outcome within the first hours of hospital care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a reliable tool to predict recovery after a brain hemorrhage, helping guide treatment decisions and reduce uncertainty for families.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve outcomes. The scale may not prove accurate enough in real-world settings, and new blood biomarkers may add little benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL HEMORRHAGE, SPONTANEOUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage Intracranial Hemorrhages

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL HEMORRHAGE, SPONTANEOUS

Contacts and locations

Locations

Neurology Department, German Trias I Pujol Hospital.

Badalona, Barcelona, 08916, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.